Recent Insider Transactions - Acadia Pharmaceuticals (NASDAQ: ACAD)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ ACAD Acadia Pharmaceuticals

Garner Thomas / officer: EVP, Chief Commercial Officer

12/09/2024

Buy

$18.76

235,849

$4.425M

235,849

NASDAQ ACAD Acadia Pharmaceuticals

Teehan Brendan / officer: EVP, COO, HEAD OF COMMERCIAL

11/19/2024

Sell

$16.81

10,329

$174K

62,105

NASDAQ ACAD Acadia Pharmaceuticals

Kihara James / officer: PRINCIPAL ACCOUNTING OFFICER

11/19/2024

Sell

$16.81

4,073

$68K

19,863

NASDAQ ACAD Acadia Pharmaceuticals

Schneyer Mark C. / officer: EVP, CHIEF FINANCIAL OFFICER

11/19/2024

Sell

$16.81

10,259

$172K

53,302